Skip to main content
. 2022 Oct 27;6(1):e001657. doi: 10.1136/bmjpo-2022-001657

Table 3.

Comparison of comorbidities between country income groups

Country income
HICs LMICs Total P value
N n % N n % N n %
Chronic neurological disorder* 2588 191 7.4 902 14 1.6 3490 205 5.9 0.001
Seizure* 2490 111 4.5 899 16 1.8 3389 127 3.7 0.001
Smoking 2091 82 3.9 1509 46 3.0 3600 128 3.6 0.215
Diabetes* 2592 95 3.7 4468 149 3.3 7060 244 3.5 0.001
Chronic cardiac disease* 2587 141 5.5 3578 48 1.3 6165 189 3.1 0.001
Obesity* 2438 90 3.7 1736 39 2.2 4174 129 3.1 0.001
Tuberculosis* 290 3649 102 2.8 3939 102 2.6 0.001
Chronic haematological disease* 2475 77 3.1 899 9 1.0 3374 86 2.5 0.001
HIV/AIDS* 2562 1 <0.01 4382 142 3.2 6944 143 2.1 0.001
Rare diseases and inborn errors of metabolism 1823 36 2.0 0 1823 36 2.0% 0.715
Malnutrition 2539 35 1.4 901 26 2.9% 3440 61 1.8% 0.412
Malignant neoplasm* 2571 64 2.5 4164 27 0.6% 6735 91 1.4% 0.001
Rheumatological disorder* 2491 45 1.8 898 2 0.2% 3389 47 1.4% 0.001
Chronic kidney disease* 2596 59 2.3 4147 28 0.7 6743 87 1.3 0.001
Liver disease 2623 12 0.5 902 3525 12 0.3 0.866

*Significant with p-value <0.05 using Chi-square test.

HICs, high-income countries; LMICs, low-income to middle-income countries; N, denominators; n, total patients with comorbidities.